RDY 329 (Nateglinide 120 mg)
Pill imprint RDY 329 has been identified as Nateglinide 120 mg.
Nateglinide is used in the treatment of diabetes, type 2 and belongs to the drug class meglitinides. Risk cannot be ruled out during pregnancy. Nateglinide 120 mg is not a controlled substance under the Controlled Substance Act (CSA).
Nateglinide
- Imprint:
- RDY 329
- Strength:
- 120 mg
- Color:
- White
- Size:
- 12.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Meglitinides
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Dr. Reddy’s Laboratories Inc.
- National Drug Code (NDC):
- 55111-0329
- Inactive Ingredients:
- carnauba wax
copovidone
croscarmellose sodium
mannitol
silicon dioxide
sodium lauryl sulfate
sodium stearyl fumarate
corn starch
magnesium silicate
More about nateglinide
Consumer resources
- Other brands: Starlix
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
